Fabian was Chief Medical Officer at ImmunoGen, and Executive Medical Director, Global Clinical Leader Xtandi, Talazoparib and Orgovyx at Pfizer. Fabian Zohren joined Genmab in 2024.
Fabian Zohren is currently
Create your alert
to follow the career of Fabian Zohren.
In 2008, Fabian Zohren completed a PhD in Medicine at Heinrich Heine University Düsseldorf.
Do you need to know more about Fabian Zohren? More results.
Report an error
Update the org chart details of Fabian Zohren.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.